Literature DB >> 10716719

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

S Hoffmeyer1, O Burk, O von Richter, H P Arnold, J Brockmöller, A Johne, I Cascorbi, T Gerloff, I Roots, M Eichelbaum, U Brinkmann.   

Abstract

To evaluate whether alterations in the multidrug-resistance (MDR)-1 gene correlate with intestinal MDR-1 expression and uptake of orally administered P-glycoprotein (PGP) substrates, we analyzed the MDR-1 sequence in 21 volunteers whose PGP expression and function in the duodenum had been determined by Western blots and quantitative immunohistology (n = 21) or by plasma concentrations after orally administered digoxin (n = 8 + 14). We observed a significant correlation of a polymorphism in exon 26 (C3435T) of MDR-1 with expression levels and function of MDR-1. Individuals homozygous for this polymorphism had significantly lower duodenal MDR-1 expression and the highest digoxin plasma levels. Homozygosity for this variant was observed in 24% of our sample population (n = 188). This polymorphism is expected to affect the absorption and tissue concentrations of numerous other substrates of MDR-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716719      PMCID: PMC16264          DOI: 10.1073/pnas.97.7.3473

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits.

Authors:  A D Long; C H Langley
Journal:  Genome Res       Date:  1999-08       Impact factor: 9.043

2.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.

Authors:  P Gros; R Dhir; J Croop; F Talbot
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.

Authors:  K V Chin; S S Chauhan; I Pastan; M M Gottesman
Journal:  Cell Growth Differ       Date:  1990-08

4.  A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1).

Authors:  K Yoshimoto; H Iwahana; Y Yokogoshi; S Saito; M Shiraishi; T Sekiya; M M Gottesman; I Pastan
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

5.  The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.

Authors:  K Ueda; D P Clark; C J Chen; I B Roninson; M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

6.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).

Authors:  A Johne; J Brockmöller; S Bauer; A Maurer; M Langheinrich; I Roots
Journal:  Clin Pharmacol Ther       Date:  1999-10       Impact factor: 6.875

8.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

9.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

Authors:  C Cordon-Cardo; J P O'Brien; J Boccia; D Casals; J R Bertino; M R Melamed
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479

10.  Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

Authors:  C J Chen; D Clark; K Ueda; I Pastan; M M Gottesman; I B Roninson
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

View more
  535 in total

1.  MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.

Authors:  T Sakaeda; T Nakamura; M Horinouchi; M Kakumoto; N Ohmoto; T Sakai; Y Morita; T Tamura; N Aoyama; M Hirai; M Kasuga; K Okumura
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

2.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

3.  Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.

Authors:  Masanori Horinouchi; Toshiyuki Sakaeda; Tsutomu Nakamura; Yoshinori Morita; Takao Tamura; Nobuo Aoyama; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

Review 4.  Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

5.  Lack of association between MDR1 C3435T polymorphism and chemotherapy response in advanced breast cancer patients: evidence from current studies.

Authors:  Guodi Chen; Sheng Quan; Qiongge Hu; Liancong Wang; Xiaoping Xia; Jing Wu
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

6.  Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects.

Authors:  Chise Kodaira; Mitsushige Sugimoto; Masafumi Nishino; Mihoko Yamade; Naohito Shirai; Shinya Uchida; Mutsuhiro Ikuma; Shizuo Yamada; Hiroshi Watanabe; Akira Hishida; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2009-02-24       Impact factor: 2.953

Review 7.  Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.

Authors:  Sridhar Mani; Mohammed Ghalib; Imran Chaudhary; Sanjay Goel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

8.  Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.

Authors:  Alan T Clucas; Ajit Shah; Yuanchao Derek Zhang; Vincent F Chow; Ronald P Gladue
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

10.  Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients.

Authors:  Yuichi Uwai; Satohiro Masuda; Maki Goto; Hideyuki Motohashi; Hideyuki Saito; Masahiro Okuda; Eijirou Nakamura; Noriyuki Ito; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Hum Genet       Date:  2003-12-18       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.